Hims & Hers Health is trading 3.33% down now at €24.40 after September 15, 2026 coverage highlighted a securities class action tied to the FTC lawsuit.
- The headline explicitly says the FTC lawsuit reveal drove the stock sharply lower.
- Related filings allege deceptive privacy and billing practices and reference a prior decline, adding legal and compliance pressure.
- Broader markets are also weaker, but the company-specific catalyst is clearer.